Home/ Stocks/ CMMB

Chemomab Therapeutics Ltd. American Depositary Share

CMMB XNAS

$1.77 +0.03 (+1.72%) ▲ 15-min delayed

Open

$1.81

High

$1.81

Low

$1.71

Volume

32.6K

Market Cap

$12.74M

About Chemomab Therapeutics Ltd. American Depositary Share

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 12 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2023	N/A	$-8,753,000	$0.04
FY 2022	N/A	$-27,646,000	$0.12
Q3 2022	N/A	$-8,080,000	$0.04
Q2 2022	N/A	$-6,190,000	$0.03

Related Market News

No specific coverage for CMMB yet. Check out our latest market news or earnings calendar.

Get CMMB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Chemomab Therapeutics Ltd. American Depositary Share.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.